Dr. Melikian is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
26357 McBean Pkwy
Ste 320
Valencia, CA 91355Phone+1 818-869-7049Fax+1 818-792-4793
Education & Training
- Stanford Health Care-Sponsored Stanford UniversityFellowship, Infectious Disease, 2009 - 2012
- University of RochesterResidency, Internal Medicine, 2005 - 2008
- New York Medical CollegeClass of 2005
Certifications & Licensure
- CA State Medical License 2009 - 2025
- NY State Medical License 2008 - 2010
- American Board of Internal Medicine Infectious Disease
- National Board of Physicians and Surgeons Infectious Disease
- National Board of Physicians and Surgeons Internal Medicine
Publications & Presentations
PubMed
- 24 citationsFactors Associated with the Development of Drug Resistance Mutations in HIV-1 Infected Children Failing Protease Inhibitor-Based Antiretroviral Therapy in South AfricaTheresa M. Rossouw, Ute Dagmar Feucht, George Melikian, Gisela Van Dyk, Winifred Nancy Thomas
Plos One. 2015-07-21 - 85 citationsNon-nucleoside reverse transcriptase inhibitor (NNRTI) cross-resistance: implications for preclinical evaluation of novel NNRTIs and clinical genotypic resistance testingGeorge L. Melikian, Soo-Yon Rhee, Vici Varghese, Danielle Porter, Kirsten L. White
The Journal of Antimicrobial Chemotherapy. 2014-01-01 - 23 citationsPrototypical Recombinant Multi-Protease-Inhibitor-Resistant Infectious Molecular Clones of Human Immunodeficiency Virus Type 1Vici Varghese, Yumi Mitsuya, W. Jeffrey Fessel, Tommy F. Liu, George L. Melikian
Antimicrobial Agents and Chemotherapy. 2013-09-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: